NIKKEI 225
38,907.51 +290.41 (+0.75%) HANG SENG
18,819.18 -376.42 (-1.96%) CRUDE OIL
76.93 -0.64 (-0.83%) GOLD FUTURES
2,374.20 -18.70 (-0.78%) DOW
39,671.04 -201.95 (-0.51%) Bitcoin GBP
54,606.84 -477.75 (-0.87%)
Integra LifeSciences Holdings Corporation (IART)
After hours:
| Previous close | 27.38 |
| Open | 27.34 |
| Bid | 28.07 x 200 |
| Ask | 28.14 x 300 |
| Day's range | 27.28 - 28.31 |
| 52-week range | 22.36 - 46.75 |
| Volume | |
| Avg. volume | 1,087,287 |
| Market cap | 2.216B |
| Beta (5Y monthly) | 1.17 |
| PE ratio (TTM) | 54.08 |
| EPS (TTM) | 0.52 |
| Earnings date | 24 Jul 2024 - 29 Jul 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 33.63 |
GlobeNewswireIntegra LifeSciences to Present at the 2024 Bank of America Healthcare Conference
PRINCETON, N.J., May 13, 2024 (GLOBE NEWSWIRE) -- Integra LifeSciences Holdings Corporation (NASDAQ: IART), a leading global medical technology company, announced today that Lea Knight, chief financial officer will present at the 2024 Bank of America Healthcare conference on Tuesday, May 14, 2024 at 4:40pm ET. A live webcast of the presentation will be available on the Integra LifeSciences investor relations website at http://investor.integralife.com/events-and-presentations. About Integra LifeS
ZacksDeciphering Integra (IART) International Revenue Trends
Examine the evolution of Integra's (IART) overseas revenue trends and their effects on Wall Street's forecasts and the stock's prospects.
ZacksIntegra's (IART) Q1 Earnings Match Estimates, Margins Down
Strong demand for Integra's (IART) diverse portfolio of leading brands and continued successful market adoption of CereLink contributes to its revenues.
